Serum biomarkers associated with SARS-CoV-2 severity
Authors:
Open Access
- 26 September 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-9
Abstract
Immunity with SARS-CoV-2 infection during the acute phase is not sufficiently well understood to differentiate mild from severe cases and identify prognostic markers. We evaluated the immune response profile using a total of 71 biomarkers in sera from patients with SARS-CoV-2 infection, confirmed by RT-PCR and controls. We correlated biological marker levels with negative control (C) asymptomatic (A), nonhospitalized (mild cases-M), and hospitalized (severe cases-S) groups. Among angiogenesis markers, we identified biomarkers that were more frequently elevated in severe cases when compared to the other groups (C, A, and M). Among cardiovascular diseases, there were biomarkers with differences between the groups, with D-dimer, GDF-15, and sICAM-1 higher in the S group. The levels of the biomarkers Myoglobin and P-Selectin were lower among patients in group M compared to those in groups S and A. Important differences in cytokines and chemokines according to the clinical course were identified. Severe cases presented altered levels when compared to group C. This study helps to characterize biological markers related to angiogenesis, growth factors, heart disease, and cytokine/chemokine production in individuals infected with SARS-CoV-2, offering prognostic signatures and a basis for understanding the biological factors in disease severity.Keywords
Funding Information
- Fundação Oswaldo Cruz (48111668950485)
This publication has 61 references indexed in Scilit:
- HB-EGF induces cardiomyocyte hypertrophy via an ERK5-MEF2A-COX2 signaling pathwayCellular Signalling, 2011
- Heparin-binding EGF-like growth factor in human serum. Association with high blood cholesterol and heart hypertrophyGrowth Factors, 2009
- Heparin-Binding Epidermal Growth Factor and Its Receptors Mediate Decidualization and Potentiate Survival of Human Endometrial Stromal CellsThe Journal of Clinical Endocrinology & Metabolism, 2005
- Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapyNature Medicine, 2002
- Lung Overexpression of the Vascular Endothelial Growth Factor Gene Induces Pulmonary EdemaAmerican Journal of Respiratory Cell and Molecular Biology, 2000
- Age-Associated Increased Interleukin-6 Gene Expression, Late-Life Diseases, and FrailtyAnnual Review of Medicine, 2000
- Heparin-binding EGF-like growth factorBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1997
- Co‐expression of TNFα and IL‐1β in human acute pulmonary fibrotic diseases: An immunohistochemical analysisPathology International, 1996
- Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques.Journal of Clinical Investigation, 1995
- Interleukin 10: a novel stimulatory factor for mast cells and their progenitors.Journal of Experimental Medicine, 1991